Leadless pacemakers are miniature, self-contained cardiac devices implanted directly into the heart right ventricle to treat slow heart rhythms. These wireless capsules eliminate the need for surgical pockets and insulated wires, significantly reducing risks of lead-related infections or mechanical failures compared to traditional systems.
- Device size: Miniature capsules measuring 1 to 1.5 inches, roughly 10% of traditional pacemaker volume.
- Implantation method: Surgeons insert the device via catheter through a leg vein under general anesthesia.
- Hospital stay: Most patients require only 1 day of hospitalization following the implantation procedure.
- Suitability: Ideal for patients with kidney failure or a high risk of recurrent infections.
Bookimed Expert Insight: Spain hosts world-renowned electrophysiologists like Dr. Josep Brugada, co-discoverer of Brugada Syndrome, at JCI-accredited centers. While US costs average $40,000, choosing leading Spanish facilities allows access to these pioneers for approximately $8,500 to $13,000.
Patient Consensus: Patients report that leadless devices offer a faster return to an active lifestyle. They value the elimination of visible chest lumps and lead-related connection issues common with older models.